← Back to Clinical Trials
Recruiting NCT06924671

NCT06924671 GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06924671
Status Recruiting
Phase
Sponsor University of Alberta
Condition Low Back Pain
Study Type OBSERVATIONAL
Enrollment 2,200 participants
Start Date 2021-06-18
Primary Completion 2027-02

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
GLA:D Back

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,200 participants in total. It began in 2021-06-18 with a primary completion date of 2027-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

GLA:D Back is a program developed in Denmark to help people with persistent low back pain. This study will assist in contextualizing Danish content into an English version of the program.

Eligibility Criteria

Inclusion Criteria: * Patients must have persistent low back pain of at least 1 month's duration. Exclusion Criteria: * Participating currently in a supervised exercise or rehabilitation program or enrolled in another interventional clinical trial. * Patients with nerve root involvement, suspected serious pathology, unstable trauma to the spine, aspects of pregnancy or other conditions that would prevent participation or disallow trial completion within the prescribed time period. * Persons with conditions that require a specialist consult are suspected of needing a specialist consult, or have conditions that would be aggravated or worsened if treated by the interventions in this study.

Contact & Investigator

Central Contact

Erin McCabe, PhD

✉ emccabe@ualberta.ca

📞 780-492-5983

Frequently Asked Questions

Who can join the NCT06924671 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06924671 currently recruiting?

Yes, NCT06924671 is actively recruiting participants. Contact the research team at emccabe@ualberta.ca for enrollment information.

Where is the NCT06924671 trial being conducted?

This trial is being conducted at Edmonton, Canada.

Who is sponsoring the NCT06924671 clinical trial?

NCT06924671 is sponsored by University of Alberta. The trial plans to enroll 2,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology